Enhancing qualitative research through virtual focus groups and artificial intelligence: A review.
Exploring AI's role in virtual focus groups: benefits, challenges, and ethical considerations in qualitative research. 🤖💬
Weekly Health & AI Digest – June 09, 2025
Here are the latest breakthroughs in health & AI (June 09, 2025 week) 🔹 Omada Health Begins Trading on Nasdaq at $19 per Share Omada Health starts trading on Nasdaq at $19 per share, raising $150 million for chronic care...
Omada Health Begins Trading on Nasdaq at $19 per Share
Omada Health starts trading on Nasdaq at $19 per share, raising $150 million for chronic care management. 📈💼
From Acquisition to Prognosis: The Role of AI in Cardiac Magnetic Resonance Imaging Evaluation of Ischemic Cardiomyopathy.
AI enhances cardiac MRI for ischemic cardiomyopathy, improving accuracy and prognosis. Key findings from PubMed article reviewed. 🫀📊
FDA Introduces AI Tool to Enhance Employee Efficiency
FDA launches Elsa, an AI tool aimed at improving employee efficiency and enhancing agency functions. 🤖📄
Systematic scoping review of external validation studies of AI pathology models for lung cancer diagnosis.
AI models for lung cancer diagnosis show AUC values from 0.746 to 0.999, but require more robust external validation. 📊🩺
ACU Collaborates with Skybox Health for Digital Nursing Education Development
ACU partners with Skybox Health to create a digital nursing education platform, enhancing training for future healthcare professionals. 📚💻
A deep learning system for detecting silent brain infarction and predicting stroke risk.
Deep learning detects silent brain infarctions via retinal images, achieving AUCs of 0.901 for incident and 0.769 for recurrent strokes. 🧠📈
NHS Scotland Seeks £206 Million Cloud Integration Solution
NHS Scotland seeks £206 million for a cloud integration solution to enhance HR, finance, and procurement processes. ☁️💰
Histopathologic deep learning model for predicting tumor response to hepatic arterial infusion chemotherapy plus TKIs and ICIs in large hepatocellular carcinoma.
Deep learning predicts tumor response in large HCC: HTI shows 54.45% ORR vs. 21.65% for HAIC. 📊🧬